BIOMAT Database Logo BIOMAT Database Logo

Synthesis and cytotoxic evaluation of substituted urea derivatives as inhibitors of human-leukemia K562 cells. 2007

Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Institute of Functional Biomolecules, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, PR China.

A series of substituted urea derivatives, compounds 1-14, were synthesized and evaluated for their cytotoxic activities against the human-leukemia K562 cell line. Two structurally simple compounds, 7 and 12, both incorporating a morpholine ring, were found to be highly active, with IC50 values of ca. 0.25 microM.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562

Related Publications

Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and Cytotoxic Evaluation of Some Substituted 5-Pyrazolones and Their Urea Derivatives.
February 2020, Molecules (Basel, Switzerland),
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and pharmacological evaluation of 1,1,3-substituted urea derivatives as potent TNF-alpha production inhibitors.
August 2010, Bioorganic & medicinal chemistry letters,
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.
December 2019, Bioorganic chemistry,
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and biological evaluation of diaryl urea derivatives as FLT3 inhibitors.
December 2020, Bioorganic & medicinal chemistry letters,
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
March 2020, Molecules (Basel, Switzerland),
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and biological evaluation of substituted imidazoquinoline derivatives as mPGES-1 inhibitors.
April 2013, Bioorganic & medicinal chemistry,
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
June 2006, Bioorganic & medicinal chemistry letters,
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors.
March 2023, Scientific reports,
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and biological evaluation of di-aryl urea derivatives as c-Kit inhibitors.
November 2015, Bioorganic & medicinal chemistry,
Ping Cao, and Xian-Feng Huang, and Hui Ding, and Hui-Ming Ge, and Huan-Qiu Li, and Ban-Feng Ruan, and Hai-Liang Zhu
Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
July 1997, Journal of medicinal chemistry,
Copied contents to your clipboard!